Ignite Creation Date:
2024-05-06 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 2:20 PM
Study NCT ID:
NCT05167500
Status:
COMPLETED
Last Update Posted:
2023-03-30
First Post:
2021-11-09
Brief Title:
Efficacy Safety Study of Lorlatinib in ALKROS1 Metastatic NSCLC Patients With Compassionate Use Treatment
Sponsor:
Fundación GECP
Organization:
Fundación GECP
Organization Data
Organization:
Fundación GECP
Class:
OTHER
Study ID:
GECP 2104_LORLAPULM
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fundación GECP
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None